Concepedia

Drew C. Deniger

DC

Statistics

Publications

19

Citations

1.8K

H-Index

15

Active since

2006

Affiliations

National Cancer Institute(Current)

National Institutes of Health

The University of Texas MD Anderson Cancer Center

University of Minnesota

Center for Cancer Research

Drew C. Deniger is an author at National Cancer Institute specializing in cancer immunology, life sciences, and oncology.

ORCID

Publications per year

2006–2023

19

Publications

19

Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers

Maria R. Parkhurst, Paul F. Robbins, Eric Tran et al. · Cancer Discovery · 2019 · 296 citations · Full text

, , +17

Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers

Parisa Malekzadeh, Anna Pasetto, Paul F. Robbins et al. · Journal of Clinical Investigation · 2019 · 269 citations · Full text

, , +17

Tumor-infiltrating human CD4 <sup>+</sup> regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity

Mojgan Ahmadzadeh, Anna Pasetto, Drew C. Deniger et al. · Science Immunology · 2019 · 194 citations · Full text

, , +16

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients

Gal Cafri, Rami Yossef, Anna Pasetto et al. · Nature Communications · 2019 · 166 citations · Full text

, , +12

Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

Winifred Lo, Maria R. Parkhurst, Paul F. Robbins et al. · Cancer Immunology Research · 2019 · 155 citations · Full text

, , +17

1–5 of 19